Metronomic Temozolamide in Patients With Recurrent Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01308632
Recruitment Status : Unknown
Verified March 2011 by Grupo Español de Investigación en Neurooncología.
Recruitment status was:  Active, not recruiting
First Posted : March 4, 2011
Last Update Posted : March 4, 2011
Information provided by:
Grupo Español de Investigación en Neurooncología

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : June 2012
  Estimated Study Completion Date : June 2012